2-(4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-2-ol, 95.0%, 100mg

1-N-Ethyl-1-N-methylbenzene-1,2-diamine, 97%, 100mg

4-Amino-2,3-difluorobenzotrifluoride, 95.0%, 1g

3-Fluoro-4-methylphenylacetonitrile, 95.0%, 5g

2-Amino-3-(pyridin-4-yl)propan-1-ol dihydrochloride, 95%, 250mg

5-Fluoro-2-(2-methoxyethoxy)aniline, 95.0%, 1g

Monomethacryloxypropylterminated polydimethylsiloxane - asymmetric cSt 150-200 inhibited with BHT, 100g

4-Methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 95.0%, 100mg

tert-Butyl (1R)-1-(hydroxymethyl)-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate, 98%, 250mg

2-Phenoxyphenol, 95.0%, 250mg

4-Fluoro-3-methyl-5-(trifluoromethyl)phenylacetic acid, 1g

(1R,4R)-1-N-(Quinazolin-4-yl)cyclohexane-1,4-diamine dihydrochloride, 1g

Methyl 3-oxopiperidine-1-carboxylate, 95%, 100mg